Treague to evaluate single-isomer mefloquine in malaria
This article was originally published in Scrip
Executive Summary
A new UK company, Treague Ltd, has been set up to evaluate if a single enantiomer of the antimalarial, mefloquine (Larium), will be of use in the prophylaxis and treatment of the disease.